Clinical Trial Update: Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) [Phase 2]

View source ↗

Summary

BLU-808 is being studied in a Phase 2 trial for Chronic Inducible Urticaria and Chronic Spontaneous Urticaria, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inducible Urticaria
• Spontaneous Urticaria

Drugs mentioned

• BLU-808

Snippet

Sponsor: Blueprint Medicines Corporation | Conditions: Chronic Inducible Urticaria, Chronic Spontaneous Urticaria | Phase 2 | Status: RECRUITING